Evidence-Based Medicine Guidelines
Intravesical BCG and antineoplastic agents in Ta and T1 bladder cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravesical BCG and Antineoplastic Agents in Ta and T1 Bladder Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453201/all/Intravesical_BCG_and_antineoplastic_agents_in_Ta_and_T1_bladder_cancer.
Intravesical BCG and antineoplastic agents in Ta and T1 bladder cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/453201/all/Intravesical_BCG_and_antineoplastic_agents_in_Ta_and_T1_bladder_cancer. Accessed November 29, 2023.
Intravesical BCG and antineoplastic agents in Ta and T1 bladder cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/453201/all/Intravesical_BCG_and_antineoplastic_agents_in_Ta_and_T1_bladder_cancer
Intravesical BCG and Antineoplastic Agents in Ta and T1 Bladder Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 November 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453201/all/Intravesical_BCG_and_antineoplastic_agents_in_Ta_and_T1_bladder_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravesical BCG and antineoplastic agents in Ta and T1 bladder cancer
ID - 453201
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453201/all/Intravesical_BCG_and_antineoplastic_agents_in_Ta_and_T1_bladder_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
